DanCann Pharma A/S has today applied for a voluntary delisting from Spotlight Stock Market

COPENHAGEN, Denmark, 7 January 2026 – DanCann Pharma A/S’, CVR-no. 39426005 (SS: DANCAN), a Danish medicinal cannabis company listed on Spotlight Stock Market (“DanCann Pharma” or the “Company”) general meeting approved on 21 October 2025 that DanCann Pharma shall apply for a voluntary delisting of its shares from Spotlight Stock Market, and the Company has today submitted to Spotlight Stock Market an application for a voluntary delisting of its shares from Spotlight Stock Market.

Application for delisting

On 6 October 2025, the Company announced that the Company has resolved to apply for a voluntary delisting of the Company’s shares pursuant to section 6.3 of the Spotlight Stock Market Regulations, subject to approval by the general meeting. On 21 October 2025, the general meeting of the Company approved that the Company shall apply for a voluntary delisting of the Company’s shares from Spotlight Stock Market. As announced on 6 October 2025, the application for a delisting will be submitted on 7 January 2026.

Accordingly, the board of directors of the Company has today submitted to Spotlight Stock Market a formal application for a voluntary delisting of the Company’s shares from Spotlight Stock Market.

The company will issue a separate press release once Spotlight Stock Market has made a decision regarding the delisting application.

For further information of the delisting, including the time plan and rationale behind the delisting, please refer to the press release “DanCann Pharma A/S has resolved to apply for delisting from Spotlight Stock Market, subject to approval by the general meeting“ dated 6 October 2025.

Further information

For further information regarding the delisting, please contact:

Carsten Trads, Chairman

E-mail: ctr@dancann.com

About DanCann Pharma A/S

DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical company powered by cannabinoids.

DanCann Pharma A/S (SS: DANCAN) is listed on the Spotlight Stock Market in Copenhagen/Stockholm.

For more information, please visit:www.dancann.com.

Forward-looking statement:

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology.

Forward-looking statements are subject to several risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company's research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities.

Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this presentation are made as of the date of this presentation and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Läs mer på Cision